RESEARCH ADMINISTRATION

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 RCMI地方咨询委员会(RLAC)行政改革： 亨利·刘易斯三世博士再次被任命为药学和药学学院院长，自2007年7月1日起生效。2007年8月，R·特纳博士被任命为文理学院院长。药学院前临时院长罗伯特·L·托马斯博士和前研究副总裁基思·杰克逊博士将不再担任RLAC特设成员。拉里·罗宾逊博士于3月20日被任命为FAMU负责研究的副总裁。罗宾逊博士曾担任FAMU环境科学研究所的教授和美国国家海洋和大气管理局局长。他将在2009年春季晚些时候担任新职位。戴尔·韦森博士目前担任研究临时副总裁。 摘要 这项申请寻求继续发展的药物研究中心在佛罗里达农工大学(FAMU)。以前资助的有针对性的研究活动证明了生产率，并产生了重大发现，这些发现已经授予了几项专利，并有更多待定的发现。根据对目前研究基础设施的评价和该方案的战略需求，建议将有针对性的活动转变为核心研究设施的开发。目前应用的主要目标是建立研究计划的基础设施，以便更好地了解分子系统的机械细节。这个RCMI中心将专注于各种方法，即基因表达分析、蛋白质组学、聚合酶链式反应分析、基因传递系统和DNA微阵列技术。在分子神经生物学、细胞成像、神经化学/受体、流式细胞仪和纳米医学领域的核心设施的建立将提高我们了解分子系统的机制细节的能力，并提供对不同分子在疾病和不利条件下如何调节的更深入的见解。药物研究中心将由一个研究行政部门和三(3)个核心服务提供设施组成。行政部门将继续提供授奖前和授奖后的援助，协调外部和内部咨询委员会的活动，提供科学研讨会和赠款研讨会，协调新的结构化指导方案，促进对方案结果的广泛外部评估，协助教师发展，雇用研究教员和市场，并举办现场赠款管理研讨会和年度RCMI R01科学家研讨会系列。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. RCMI Local Advisory Committee (RLAC) Administrative Changes: Dr. Henry Lewis III has been reappointed as Dean, College of Pharmacy and Pharmaceutical Sciences, effective July 1, 2007. Dr. R. Turner has been appointed Dean, College of Arts and Sciences, August 2007. Dr. Robert L. Thomas, former Interim Dean of the College of Pharmacy and Dr. Keith Jackson, former Vice President of Research will no longer serve as Ad-Hoc members of the RLAC. Dr. Larry Robinson was appointed as FAMU's Vice President for Research on March 20th. Dr. Robinson served as a professor in the Environmental Sciences Institute at FAMU and director of the National Oceanic and Atmospheric Administration. He will assume his new position later in Spring 2009. Dr. Dale Wesson currently serves as Interim Vice President for Research. Abstract This application seeks to continue the evolution of the Pharmaceutical Research Center at Florida A&M University (FAMU). The previously funded targeted research activities have demonstrated productivity and resulted in significant discoveries that have led to the award of several patents and additional pending discoveries. Based on the evaluation of the current research infrastructure and the strategic needs of the program, it is proposed to transition the targeted activities into the development of Core research facilities. The main objective of the current application is to build the infrastructure of the research program towards more understanding of the mechanistic details of the molecular system. This RCMI center will focus efforts on approaches, i.e., gene expression analysis, proteomics, PCR analysis, gene delivery systems and DNA microarray techniques. The establishment of Core facilities in the areas of molecular neurobiology, cellular imaging, neurochemistry/receptors, flow cytometer and Nanomedicine will increase our abilities to understand the mechanistic details of the molecular system and to provide greater insights into how the different molecular are modulated under disease and adverse conditions. The Pharmaceutical Research Center will consist of a research administrative component coupled with three (3) core service delivery facilities. The administrative component will continue to provide pre- and post- award assistance, coordinate the activities of the external and internal advisory committee, provide scientific seminars and grants workshops, coordinate a new structured mentoring program, facilitate an extensive external evaluation of program outcomes, assist in faculty development, hire a research faculty member and market and conduct an on-site grants management workshop and the annual RCMI R01 Scientist Seminar Series.